Laboratories
The dramatic rise in opioid use and abuse in the United States has created a unique set of market challenges and pressures for laboratories that run toxicology and pain management panels. While the Centers for Disease Control and other experts acknowledge the importance of repeated drug testing to ensure the safety of patients who are taking opioids long term, federal, state, and private payers are reducing test reimbursements to cut overall healthcare costs. Like everything…
Subscribe to the blog